A Review on Brown Seaweed Fucoidan in Cancer: Implications in Metastasis and Drug Resistance

Authors

  • María Elena Reyes Laboratory of Integrative Biology (LIBi), Center of Excellence in Translational Medicine- Scientific and Technological Bioresource Nucleus (CEMT-BIOREN), Universidad de La Frontera, Temuco 4710296, Chile.
  • Ismael Riquelme Instituto de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Temuco 4810101, Chile.
  • Tomás Salvo Laboratory of Integrative Biology (LIBi), Center of Excellence in Translational Medicine- Scientific and Technological Bioresource Nucleus (CEMT-BIOREN), Universidad de La Frontera, Temuco 4710296, Chile.
  • Louise Zanella Laboratory of Integrative Biology (LIBi), Center of Excellence in Translational Medicine- Scientific and Technological Bioresource Nucleus (CEMT-BIOREN), Universidad de La Frontera, Temuco 4710296, Chile.
  • Pablo Letelier Precision Health Research Laboratory, Departamento de Procesos Diagnósticos y Evaluación, Facultad Ciencias de la Salud, Universidad Católica de Temuco, Temuco 4813302, Chile.
  • Priscilla Brebi Laboratory of Integrative Biology (LIBi), Center of Excellence in Translational Medicine- Scientific and Technological Bioresource Nucleus (CEMT-BIOREN), Universidad de La Frontera, Temuco 4710296, Chile.

DOI:

https://doi.org/10.9734/bpi/tipr/v1/7082D

Keywords:

Fucoidan, cancer, metastasis, epithelial mesenchymal transition, nanoparticles

Abstract

Fucoidans are sulphated polysaccharides that can be obtained from brown seaweed and marine invertebrates. They have anti-cancer properties, through their targeting of several signaling pathways and molecular mechanisms within malignant cells. This review describes the chemical structure diversity of fucoidans and their similarity with other molecules such as glycosaminoglycan, which enable them to participation in diverse biological processes. Furthermore, this review summarizes their influence on the development of metastasis and drug resistance, which are the main obstacles to cure cancer. In some cancer types, fucoidans can inhibit metastasis processes including EMT, migration, invasion and MET processes. Finally, this article discusses how fucoidans have been used in clinical trials to evaluate their potential synergy with other anti-cancer therapies.

Published

2021-02-20

How to Cite

María Elena Reyes, Ismael Riquelme, Tomás Salvo, Louise Zanella, Pablo Letelier, & Priscilla Brebi. (2021). A Review on Brown Seaweed Fucoidan in Cancer: Implications in Metastasis and Drug Resistance. Technological Innovation in Pharmaceutical Research Vol. 1, 50–74. https://doi.org/10.9734/bpi/tipr/v1/7082D